TheChemical_Industry generated ~USD57billion in net profits and…

TheChemical_Industry generated ~USD57billion in net profits and invested ~USD73billion in CAPEX in YR2024, yet TSR remains structurally weak. WHY?

Dr. Anju Sharma
KtalystInsights™ MrsSustainability

KtalystKlues

This is not a DemandParadox; it is a ValueCapture problem.

1) The industry is still profitable

✓ Global Top-50 chemical companies reported #~USD57billion net profit in 2024
✓ Average sector EBITDA margins ~12–15% for large integrated players
✓ A majority of listed chemical companies remained cash-positive despite margin pressure

KtalystInsights:
Profitability exists; this is not a demand-led downturn.

2) Capital investment has not stopped

✓ Global chemical CAPEX in 2024: ~USD73billion (Top-50 companies)
✓ R&D spend grew ~2–4% YoY in 2024 despite earnings pressure

KtalystInsights:
Industries facing structural demand decline do not sustain this level of investment.

3) Volumes are growing faster than pricing

✓ Global chemical market size grew from #~USD6.18trillion (2024) to #~USD6.32trillion (2025E)
✓ Packaging, electronics, mobility & construction chemicals showed #~1.5–3% volume growth
✓ Real pricing power across bulk and semi-specialty chains remained flat to negative

KtalystInsights:
Demand growth exists, but value per unit has diluted.

4) TSR is weak because capital intensity has risen

✓ Chemical sector 5-year TSR ~2–3% p.a. vs #~8–9% for MSCI World
✓ Average CAPEX-to-sales ratio increased ~150–250 bps vs pre-2015 levels
✓ Energy transition and ESG CAPEX raised fixed costs without near-term pricing upside

KtalystInsights:
Returns compress when each dollar of profit requires more capital.

5) Overcapacity is real—but uneven

✓ China accounted for #~40%+ of global new petrochemical capacity additions (2019–2024)
✓ Utilisation in multiple commodity chains remains #~70–80%, below mid-cycle norms
✓ Specialty chemicals show #~40–50% lower EBITDA volatility vs commodity chemicals

KtalystInsights:
McKinsey’s conclusion fits commodity and aging specialty chains, not the entire sector.

6) Segment data shows divergence, not uniform decline

✓ Regulation-linked chemicals often sustain ROIC in the high-teens to low-20% range
✓ Application-embedded specialties outperform sector TSR by ~300–500 bps
✓ Commodity chemicals trend at or near cost of capital

KtalystInsights:
The issue is business-model selectivity, not sector weakness.

7) What McKinsey measures vs what boards must decide

✓ McKinsey evaluates relative investor returns (TSR)
✓ Boards must manage absolute cash generation and capital efficiency
✓ Demographics support demand; strategy decides economic rent

KtalystInsights:
Chemicals are essential—but not all are equally rewarded.

> This is not a low-demand cycle.
It is a high-capital, low-pricing-power environment.

Dr. Anju Sharma
KtalystInsights™ MrsSustainability Chemicals Strategy ValueCapture TSR BoardroomLens DataComa

Originally published on LinkedIn on 2025-12-28 10:35:57: https://www.linkedin.com/feed/update/urn%3Ali%3Ashare%3A7410991894211543040

WhatsApp